Extract notice to the Minister

Sandoz Dapagliflozin

Common name / Subject : dapagliflozine (insuffisance cardiaque, fraction d'éjection >40%)
Name of the manufacturer : Sandoz
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription - Avec conditions

Minister's decisions
Inscrire aux listes des
médicaments - Médicament
d'exception

Evaluation published on April 01, 2026

Subscribe to our newsletter now

Subscription